Operating Margin Is the Only One That Compares Two Companies

EBITDA margin is a different number wearing similar clothes

Operating income is charged with depreciation; EBITDA is not. Add back 15,000 of depreciation to this business and EBITDA becomes 75,000, a margin of 37.5 % against the 30 % above — seven and a half points of difference produced entirely by which costs were counted. Neither figure is dishonest, and both have uses: EBITDA approximates cash generation before capital spending, while operating income recognises that the machinery wears out and will have to be replaced. What is not defensible is quoting one company's EBITDA margin against another's operating margin, which is a comparison of two different definitions dressed as a comparison of two businesses.

One-off items belong outside the trend

A legal settlement, a restructuring charge or the profit on selling a building can all land inside operating income and move the margin by several points in a year that was otherwise ordinary. Reading a series of margins without separating those out produces a trend that never happened, and the corrective is to compute the margin twice — once as reported and once with the identified one-offs removed — and to say which of the two any conclusion rests on. A company that reports an adjusted figure is doing exactly this; whether the adjustments are reasonable is a separate question worth asking every time.

Frequently asked questions

Can a company have a good operating margin and still fail?

Easily, and the usual route is timing rather than profitability. A margin is an annual proportion; a payment date is a specific Tuesday. A business earning 30 % on paper can run out of money because its customers pay at ninety days and its suppliers at thirty, or because it is growing fast enough that every new order consumes cash before it produces any. Margin describes whether the business model works and cash flow describes whether it survives long enough to prove it, and only the second has a deadline.

Where does research and development sit?

Inside operating expenses, so it reduces the operating margin of the year in which it is spent even though the benefit arrives later. That timing mismatch is the honest weakness of the measure: a company investing heavily in a product that will sell in three years looks worse today than one that has stopped investing, and the second looks better right up until its catalogue ages. Read the margin alongside the research line rather than instead of it, and a low margin caused by deliberate investment stops resembling a low margin caused by weak pricing.